speb/financial-data huggingface dataset:
Financial ratios for COV.V — annual report dated 2024-09-30
Total revenue: 23087801.48148148
Gross profit: 14024240.74074074
Operating income: 1593357.7777777778
Net income: 1977623.7037037036
Capital expenditures: 215292.59259259258
Operating cash flow: 2572581.4814814813
Depreciation & amortization: 730709.6296296295
Net tangible assets: 19307328.888888888
Owner earnings: 2493040.7407407407
Return on net tangible assets (%): 12.912406242664943
Capex to operating income (%): 13.511880105976989
Buffett classification: The Great
Stock price: 2.3185185185185184
P/E ratio: 32.37876996035646
Shares outstanding: 27618077
Book value: 20373783.7037037
P/B ratio: 3.1429126715785225
Market cap (USD): 64033022.97037037
Debt to equity: 0.032782543201488275
Current ratio: 7.266355583347534
Quick ratio: 5.340580683857823
COGS to revenue (%): 39.25692425937802
R&D to revenue (%): 5.114385881247149
SG&A to revenue (%): 42.39487762850044
Free cash flow (dilution-adjusted): 1963088.1481481483
Buyback yield (%): 0
Retained earnings: -26441845.185185183
Inventory turnover: 1.5898744088552048
Receivables turnover: 7.971532335203761
Capitalized R&D asset: 2211192.9400919164
ROCI (R&D-adjusted, %): 7.449306215720693
Rosenberg metric: 3.234244076536959
FCF margin (%): 8.502707153484163
Revenue growth (%): 17.19570152394677
Rule of 40 score: 25.698408677430933
Financial ratios for COV.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3185185185185184
Shares outstanding: 27618077
Market cap (USD): 64033022.97037037
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COV.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.1188811188811187
Shares outstanding: 27618077
Market cap (USD): 58519421.89510489
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COV.V — quarterly report dated 2025-03-31
Total revenue: 5304872.7272727275
Gross profit: 2894759.4405594408
Operating income: 197076.9230769231
Net income: 300097.2027972028
Capital expenditures: 14386.013986013986
Operating cash flow: 472094.4055944056
Depreciation & amortization: 163371.32867132867
Net tangible assets: 20782825.174825177
Owner earnings: 449082.51748251746
Return on net tangible assets (%): 2.160834793656946
Capex to operating income (%): 7.299694840678447
Buffett classification: The Great
Stock price: 1.4405594405594406
P/E ratio: 33.143829050727156
Shares outstanding: 27618077
Book value: 21783185.314685315
P/B ratio: 1.8264308446031465
Market cap (USD): 39785481.55244756
Debt to equity: 0.01956548572863107
Current ratio: 8.39154336888622
Quick ratio: 6.093644043482747
COGS to revenue (%): 45.43206615161044
R&D to revenue (%): 4.22436530183096
SG&A to revenue (%): 38.80133688937259
Free cash flow (dilution-adjusted): 403487.41258741263
Buyback yield (%): 0
Retained earnings: -23819095.104895107
Inventory turnover: 0.3859256141312703
Receivables turnover: 1.5118100444317786
Capitalized R&D asset: 224097.2027972028
ROCI (R&D-adjusted, %): 1.5688643536995395
FCF margin (%): 7.605977246410742
Rule of 40 score: 7.605977246410742
Financial ratios for COV.V — quarterly report dated 2025-06-30
Total revenue: 6111260.583941605
Gross profit: 2841237.226277372
Operating income: -57417.518248175176
Net income: 47129.19708029197
Capital expenditures: 292451.82481751824
Operating cash flow: 1574299.9999999998
Depreciation & amortization: 157702.9197080292
Net tangible assets: 20681201.459854014
Owner earnings: -87619.70802919706
Return on net tangible assets (%): -0.4236683647189594
Buffett classification: The Gruesome
Stock price: 1.635036496350365
P/E ratio: 130.04933919179626
Shares outstanding: 27618077
Book value: 21662733.576642334
P/B ratio: 2.084527499461301
Market cap (USD): 45156563.8540146
Debt to equity: 0.04305166681857521
Current ratio: 6.574014595515686
Quick ratio: 4.905014787153045
COGS to revenue (%): 53.50816435903234
R&D to revenue (%): 3.718634990785826
SG&A to revenue (%): 36.350678244193716
Free cash flow (dilution-adjusted): 1211892.7007299268
Buyback yield (%): 0
Retained earnings: -24815137.956204377
Inventory turnover: 0.556100879223731
Receivables turnover: 1.7753015812567228
Capitalized R&D asset: 377400.6003266806
ROCI (R&D-adjusted, %): 0.08588006631889325
Rosenberg metric: -0.23883481638324564
FCF margin (%): 19.830486428845543
Revenue growth (%): 15.200889788046753
Rule of 40 score: 35.0313762168923
Financial ratios for COV.V — annual report dated 2025-09-30
Total revenue: 23608882.73381295
Gross profit: 12569686.330935253
Operating income: 1268828.7769784173
Net income: 1480639.568345324
Capital expenditures: 463437.4100719425
Operating cash flow: 1646910.7913669066
Depreciation & amortization: 687009.3525179856
Net tangible assets: 21133982.01438849
Owner earnings: 1704211.510791367
Return on net tangible assets (%): 8.063844805163084
Capex to operating income (%): 36.52481867376701
Buffett classification: The Good
Stock price: 1.4100719424460433
P/E ratio: 26.301793032274112
Shares outstanding: 27618077
Book value: 22105689.928057555
P/B ratio: 1.7616946410066825
Market cap (USD): 38943475.482014395
Debt to equity: 0.07334743628133894
Current ratio: 8.363190329197915
Quick ratio: 6.400217866772904
COGS to revenue (%): 46.75865659270363
R&D to revenue (%): 4.022230140362668
SG&A to revenue (%): 37.850971041962715
Free cash flow (dilution-adjusted): 840364.7482014389
Buyback yield (%): 0
Retained earnings: -24200289.208633095
Inventory turnover: 2.0733582793289416
Receivables turnover: 5.536457039008698
Capitalized R&D asset: 2086207.0563815613
ROCI (R&D-adjusted, %): 4.571166373899143
Rosenberg metric: -1.2318388569433565
FCF margin (%): 3.559527817035821
Revenue growth (%): 2.2569548371655217
Rule of 40 score: 5.816482654201343
Financial ratios for COV.V — quarterly report dated 2025-09-30
Total revenue: 6253217.26618705
Gross profit: 3198127.3381294967
Operating income: 176867.6258992806
Net income: 257796.40287769787
Capital expenditures: 82014.38848920864
Operating cash flow: -480007.91366906476
Depreciation & amortization: 178520.86330935254
Net tangible assets: 21133982.01438849
Owner earnings: 354302.87769784173
Return on net tangible assets (%): 1.6764605811466309
Capex to operating income (%): 46.370492096678404
Buffett classification: The Good
Stock price: 1.4100719424460433
P/E ratio: 64.36695493900565
Shares outstanding: 27618077
Book value: 22105689.928057555
P/B ratio: 1.7616946410066825
Market cap (USD): 38943475.482014395
Debt to equity: 0.07334743628133894
Current ratio: 8.363190329197915
Quick ratio: 6.400217866772904
COGS to revenue (%): 48.85628945882477
R&D to revenue (%): 3.621859343311276
SG&A to revenue (%): 41.89090807011343
Free cash flow (dilution-adjusted): -655438.1294964029
Buyback yield (%): 0
Retained earnings: -24200289.208633095
Inventory turnover: 0.5738004620319433
Receivables turnover: 1.4664255458496496
Capitalized R&D asset: 452695.97861923825
ROCI (R&D-adjusted, %): 0.7476455992409943
Rosenberg metric: 1.5704357077067226
FCF margin (%): -10.481614528900922
Revenue growth (%): 2.322870712115618
Rule of 40 score: -8.158743816785304
Financial ratios for COV.V — quarterly report dated 2025-12-31
Total revenue: 5027957.6642335765
Gross profit: 2925716.0583941606
Operating income: 38134.30656934306
Net income: 91516.05839416057
Capital expenditures: 476311.67883211677
Operating cash flow: 4198503.6496350365
Depreciation & amortization: 177019.70802919706
Net tangible assets: 18297430.656934306
Owner earnings: -207775.91240875912
Return on net tangible assets (%): -1.1355469317218962
Capex to operating income (%): 1249.037210014547
Buffett classification: The Gruesome
Stock price: 1.27007299270073
P/E ratio: 50.35896152319336
Shares outstanding: 27618077
Book value: 19263974.452554744
P/B ratio: 1.8208586080935842
Market cap (USD): 35076973.708029196
Debt to equity: 0.07824714980820635
Current ratio: 5.693721884747989
Quick ratio: 4.2936049088819574
COGS to revenue (%): 41.81104428928929
R&D to revenue (%): 4.199264201830872
SG&A to revenue (%): 43.218517422726244
Free cash flow (dilution-adjusted): 3624721.1678832117
Buyback yield (%): 0
Retained earnings: -27485939.41605839
Inventory turnover: 0.42214367481667253
Receivables turnover: 3.154390285563298
Capitalized R&D asset: 437874.96450139163
ROCI (R&D-adjusted, %): 0.13277456285821398
Rosenberg metric: -1.202790495986853
FCF margin (%): 72.09132236072112
Revenue growth (%): -19.59406733840524
Rule of 40 score: 52.49725502231588
Financial ratios for DMRC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.48
Shares outstanding: 22406927
Market cap (USD): 884625477.9599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMRC — annual report dated 2022-12-31
Total revenue: 30197000
Gross profit: 15323000
Operating income: -59634000
Net income: -59798000
Capital expenditures: 934000
Operating cash flow: -44408000
Depreciation & amortization: 8579000
Net tangible assets: 56191000
Owner earnings: -52153000
Return on net tangible assets (%): -92.81379580359844
Buffett classification: The Gruesome
Stock price: 18.49
Shares outstanding: 22406927
Book value: 97590000
P/B ratio: 4.245353829593196
Market cap (USD): 414304080.22999996
Debt to equity: 0.06124602930628138
Current ratio: 6.3292875468719165
Quick ratio: 6.3292875468719165
COGS to revenue (%): 49.256548663774545
R&D to revenue (%): 87.72394608735968
SG&A to revenue (%): 161.1517700433818
Free cash flow (dilution-adjusted): -57164000
Buyback yield (%): 0.5686644453735701
Retained earnings: -265809000
Receivables turnover: 5.564215957250783
Capitalized R&D asset: 26490000
ROCI (R&D-adjusted, %): -32.25469327534138
FCF margin (%): -189.30357320263602
Rule of 40 score: -189.30357320263602
Financial ratios for DMRC — annual report dated 2023-12-31
Total revenue: 34851000
Gross profit: 20165000
Operating income: -47273000
Net income: -45959000
Capital expenditures: 314000
Operating cash flow: -21995000
Depreciation & amortization: 8128000
Net tangible assets: 24828000
Owner earnings: -38145000
Return on net tangible assets (%): -153.63702271628804
Buffett classification: The Gruesome
Stock price: 36.12
Shares outstanding: 22406927
Book value: 61927000
P/B ratio: 13.069229952040304
Market cap (USD): 809338203.2399999
Debt to equity: 0.09679138340303906
Current ratio: 2.9604790419161677
Quick ratio: 2.9604790419161677
COGS to revenue (%): 42.13939341769246
R&D to revenue (%): 76.25893087716278
SG&A to revenue (%): 116.1516168833032
Free cash flow (dilution-adjusted): -33893000
Buyback yield (%): 0.3365712861564042
Retained earnings: -311768000
Receivables turnover: 5.995355238259075
Capitalized R&D asset: 44325300
ROCI (R&D-adjusted, %): -34.164854658071086
Rosenberg metric: 0.18278595696489242
FCF margin (%): -97.25115491664515
Revenue growth (%): 15.412127032486673
Rule of 40 score: -81.83902788415847
Financial ratios for DMRC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.88
Shares outstanding: 22406927
Market cap (USD): 602298197.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMRC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.45
Shares outstanding: 22406927
Market cap (USD): 839139416.1500001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DMRC — annual report dated 2024-12-31
Total revenue: 38418000
Gross profit: 24239000
Operating income: -40757000
Net income: -39010000
Capital expenditures: 212000
Operating cash flow: -26572000
Depreciation & amortization: 7595000
Net tangible assets: 30636000
Owner earnings: -31627000
Return on net tangible assets (%): -103.23475649562606
Buffett classification: The Gruesome
Stock price: 37.45
Shares outstanding: 22406927
Book value: 61359000
P/B ratio: 13.675897849541224
Market cap (USD): 839139416.1500001
Debt to equity: 0.09768738082432894
Current ratio: 4.304114685926899
Quick ratio: 4.304114685926899
COGS to revenue (%): 36.907178926544844
R&D to revenue (%): 68.22062574834713
SG&A to revenue (%): 99.5366755166849
Free cash flow (dilution-adjusted): -37244000
Buyback yield (%): 0.4070837258095589
Retained earnings: -350778000
Receivables turnover: 5.991578290704928
Capitalized R&D asset: 52757290
ROCI (R&D-adjusted, %): -34.32025279943059
Rosenberg metric: 0.15329043910147871
FCF margin (%): -96.94414076734864
Revenue growth (%): 10.23500043040372
Rule of 40 score: -86.70914033694493
Financial ratios for DMRC — quarterly report dated 2025-03-31
Total revenue: 9368000
Gross profit: 6085000
Operating income: -11992000
Net income: -11730000
Capital expenditures: 55000
Operating cash flow: -5486000
Depreciation & amortization: 1840000
Net tangible assets: 20101000
Owner earnings: -9945000
Return on net tangible assets (%): -49.47515049002537
Buffett classification: The Gruesome
Stock price: 12.82
Shares outstanding: 22406927
Book value: 50017000
P/B ratio: 5.743183400443849
Market cap (USD): 287256804.14
Debt to equity: 0.10002599116300458
Current ratio: 2.7024121657052964
Quick ratio: 2.7024121657052964
COGS to revenue (%): 35.04483347566183
R&D to revenue (%): 81.49017933390265
SG&A to revenue (%): 109.51110162254483
Free cash flow (dilution-adjusted): -6889000
Buyback yield (%): 0.5378462677761378
Retained earnings: -362508000
Receivables turnover: 1.4476896924741154
Capitalized R&D asset: 7634000
ROCI (R&D-adjusted, %): -11.006931156184887
FCF margin (%): -73.53757472245942
Rule of 40 score: -73.53757472245942
Financial ratios for DMRC — quarterly report dated 2025-06-30
Total revenue: 8010000
Gross profit: 4707000
Operating income: -8426000
Net income: -8220000
Capital expenditures: 198000
Operating cash flow: -4688000
Depreciation & amortization: 2180000
Net tangible assets: 16681000
Owner earnings: -6238000
Return on net tangible assets (%): -37.39583957796295
Buffett classification: The Gruesome
Stock price: 13.21
Shares outstanding: 22406927
Book value: 46483000
P/B ratio: 6.3678227668179765
Market cap (USD): 295995505.67
Debt to equity: 0.1208398769442592
Current ratio: 2.6641909814323608
Quick ratio: 2.6641909814323608
COGS to revenue (%): 41.235955056179776
R&D to revenue (%): 56.62921348314607
SG&A to revenue (%): 103.73283395755305
Free cash flow (dilution-adjusted): -8777000
Buyback yield (%): 0.16993501264873442
Retained earnings: -370728000
Receivables turnover: 1.2598301352626613
Capitalized R&D asset: 9650780
ROCI (R&D-adjusted, %): -13.033351932101484
Rosenberg metric: -0.18050825255436206
FCF margin (%): -109.57553058676655
Revenue growth (%): -14.496157130657558
Rule of 40 score: -124.07168771742411
Financial ratios for DMRC — quarterly report dated 2025-09-30
Total revenue: 7627000
Gross profit: 4446000
Operating income: -8303000
Net income: -8152000
Capital expenditures: 221000
Operating cash flow: -2596000
Depreciation & amortization: 2101000
Net tangible assets: 13562000
Owner earnings: -6272000
Return on net tangible assets (%): -46.24686624391683
Buffett classification: The Gruesome
Stock price: 9.77
Shares outstanding: 22406927
Book value: 41387000
P/B ratio: 5.2894792275352165
Market cap (USD): 218915676.79
Debt to equity: 0.1309106724333728
Current ratio: 2.3053936632404364
Quick ratio: 2.3053936632404364
COGS to revenue (%): 41.70709322145011
R&D to revenue (%): 56.57532450504785
SG&A to revenue (%): 107.60456273764258
Free cash flow (dilution-adjusted): -6939000
Buyback yield (%): 0.19139789627854548
Retained earnings: -378880000
Receivables turnover: 1.2066128777092233
Capitalized R&D asset: 9873340
ROCI (R&D-adjusted, %): -16.972923864006127
Rosenberg metric: -0.057539682539682536
FCF margin (%): -90.9794152353481
Revenue growth (%): -4.781523096129837
Rule of 40 score: -95.76093833147793
Financial ratios for DMRC — quarterly report dated 2025-12-31
Total revenue: 8908000
Gross profit: 5658000
Operating income: -4259000
Net income: -4207000
Capital expenditures: 96000
Operating cash flow: 991000
Depreciation & amortization: 2169000
Net tangible assets: 14128000
Owner earnings: -2134000
Return on net tangible assets (%): -15.10475651189128
Buffett classification: The Gruesome
Stock price: 6.56
Shares outstanding: 22406927
Book value: 40229000
P/B ratio: 3.6538179204056775
Market cap (USD): 146989441.12
Debt to equity: 0.12958313654328968
Current ratio: 2.5550766283524906
Quick ratio: 2.5550766283524906
COGS to revenue (%): 36.48405927256399
R&D to revenue (%): 44.86977997305793
SG&A to revenue (%): 63.639425235743154
Free cash flow (dilution-adjusted): -2364000
Buyback yield (%): 0.2802922419874019
Retained earnings: -383087000
Receivables turnover: 1.3677260862889606
Capitalized R&D asset: 8384930
ROCI (R&D-adjusted, %): -8.576310449102643
Rosenberg metric: 0.2808806488991889
FCF margin (%): -26.53794342164347
Revenue growth (%): 16.795594598138194
Rule of 40 score: -9.742348823505274
Financial ratios for DMRC — annual report dated 2025-12-31
Total revenue: 33913000
Gross profit: 20896000
Operating income: -32980000
Net income: -32309000
Capital expenditures: 570000
Operating cash flow: -11779000
Depreciation & amortization: 8290000
Net tangible assets: 14128000
Owner earnings: -24589000
Return on net tangible assets (%): -174.04445073612683
Buffett classification: The Gruesome
Stock price: 6.56
Shares outstanding: 22406927
Book value: 40229000
P/B ratio: 3.6538179204056775
Market cap (USD): 146989441.12
Debt to equity: 0.12958313654328968
Current ratio: 2.5550766283524906
Quick ratio: 2.5550766283524906
COGS to revenue (%): 38.38351074809071
R&D to revenue (%): 60.39571845604931
SG&A to revenue (%): 95.66832777990741
Free cash flow (dilution-adjusted): -24969000
Buyback yield (%): 1.9586440890333252
Retained earnings: -383087000
Receivables turnover: 5.206970674036542
Capitalized R&D asset: 46812440
ROCI (R&D-adjusted, %): -40.38645449065491
Rosenberg metric: -0.12755160441069863
FCF margin (%): -73.6266328546575
Revenue growth (%): -11.726274142329117
Rule of 40 score: -85.35290699698662
Financial ratios for EIG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.77
Shares outstanding: 18242921
Market cap (USD): 634306363.1700001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EIG — annual report dated 2022-12-31
Total revenue: 713500000
Net income: 48400000
Capital expenditures: 2600000
Operating cash flow: 99800000
Depreciation & amortization: 5300000
Net tangible assets: 894400000
Owner earnings: 51100000
Return on net tangible assets (%): 5.713327370304114
Buffett classification: The Gruesome
Stock price: 39.14
P/E ratio: 14.752643139256199
Shares outstanding: 18242921
Book value: 944200000
P/B ratio: 0.7562252996610888
Market cap (USD): 714027927.94
Debt to equity: 0.20768904893031137
Effective tax rate (%): 13.261648745519713
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 92100000
Buyback yield (%): 4.257536548704089
Retained earnings: 1295600000
Receivables turnover: 0.9253015173129295
Capitalized R&D asset: 0
FCF margin (%): 12.908199018920813
Rule of 40 score: 12.908199018920813
Financial ratios for EIG — annual report dated 2023-12-31
Total revenue: 850900000
Net income: 118100000
Capital expenditures: 2200000
Operating cash flow: 49400000
Depreciation & amortization: 4800000
Net tangible assets: 964100000
Owner earnings: 120700000
Return on net tangible assets (%): 12.519448190021782
Buffett classification: The Gruesome
Stock price: 36.75
P/E ratio: 5.676776856477562
Shares outstanding: 18242921
Book value: 1013900000
P/B ratio: 0.6612361640694349
Market cap (USD): 670427346.75
Debt to equity: 0.005819114311076043
Effective tax rate (%): 20.4177897574124
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 41000000
Buyback yield (%): 11.350968955682744
Retained earnings: 1384300000
Receivables turnover: 1.0538766410701015
Capitalized R&D asset: 0
FCF margin (%): 4.818427547302856
Revenue growth (%): 19.25718290119131
Rule of 40 score: 24.075610448494167
Financial ratios for EIG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.64
Shares outstanding: 18242921
Market cap (USD): 832606914.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EIG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.02
Shares outstanding: 18242921
Market cap (USD): 894267987.4200001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EIG — annual report dated 2024-12-31
Total revenue: 880700000
Net income: 118600000
Capital expenditures: 4900000
Operating cash flow: 76400000
Depreciation & amortization: 3600000
Net tangible assets: 1018900000
Owner earnings: 117300000
Return on net tangible assets (%): 11.512415349887133
Buffett classification: The Gruesome
Stock price: 49.02
P/E ratio: 7.540202254806071
Shares outstanding: 18242921
Book value: 1068700000
P/B ratio: 0.8367811241882662
Market cap (USD): 894267987.4200001
Debt to equity: 0.003930008421446618
Effective tax rate (%): 19.154737559645536
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 65200000
Buyback yield (%): 4.763672702061354
Retained earnings: 1472900000
Receivables turnover: 1.1234851384105116
Capitalized R&D asset: 0
FCF margin (%): 7.403201998410355
Revenue growth (%): 3.5021741685274415
Rule of 40 score: 10.905376166937797
Financial ratios for EIG — quarterly report dated 2025-03-31
Total revenue: 202600000
Net income: 12800000
Capital expenditures: 500000
Operating cash flow: 14600000
Depreciation & amortization: 3400000
Net tangible assets: 1025900000
Owner earnings: 15700000
Return on net tangible assets (%): 1.5303635831952431
Buffett classification: The Gruesome
Stock price: 48.74
P/E ratio: 17.366405655078125
Shares outstanding: 18242921
Book value: 1075700000
P/B ratio: 0.8265873101608255
Market cap (USD): 889159969.5400001
Debt to equity: 0.003532583434042949
Effective tax rate (%): 19.49685534591195
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 12900000
Buyback yield (%): 2.226820895934325
Retained earnings: 1478500000
Receivables turnover: 0.256488163058615
Capitalized R&D asset: 0
FCF margin (%): 6.367226061204343
Rule of 40 score: 6.367226061204343
Financial ratios for EIG — quarterly report dated 2025-06-30
Total revenue: 246300000
Net income: 29700000
Capital expenditures: 900000
Operating cash flow: 0
Depreciation & amortization: 900000
Net tangible assets: 1033300000
Owner earnings: 29700000
Return on net tangible assets (%): 2.874286267298945
Buffett classification: The Gruesome
Stock price: 45.7
P/E ratio: 19.616505640000003
Shares outstanding: 18242921
Book value: 1083100000
P/B ratio: 0.7697363952543625
Market cap (USD): 833701489.7
Debt to equity: 0.003139137660419167
Effective tax rate (%): 19.72972972972973
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -2500000
Buyback yield (%): 2.8187547090093674
Retained earnings: 1500200000
Receivables turnover: 0.3120486507031547
Capitalized R&D asset: 0
FCF margin (%): -1.0150223304912709
Revenue growth (%): 21.56959526159921
Rule of 40 score: 20.55457293110794
Financial ratios for EIG — quarterly report dated 2025-09-30
Total revenue: 239300000
Net income: -8300000
Capital expenditures: 600000
Operating cash flow: 29400000
Depreciation & amortization: 8700000
Net tangible assets: 989400000
Owner earnings: -200000
Return on net tangible assets (%): -0.020214271275520515
Buffett classification: The Gruesome
Stock price: 41.47
P/E ratio: 22.120875259356726
Shares outstanding: 18242921
Book value: 1039200000
P/B ratio: 0.7279964721612779
Market cap (USD): 756533933.87
Debt to equity: 0.003945342571208622
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 27700000
Buyback yield (%): 6.001052691418515
Retained earnings: 1484400000
Receivables turnover: 0.3139184048274957
Capitalized R&D asset: 0
FCF margin (%): 11.575428332636857
Revenue growth (%): -2.8420625253755585
Rule of 40 score: 8.733365807261299
Financial ratios for EIG — quarterly report dated 2025-12-31
Total revenue: 170500000
Net income: -23400000
Capital expenditures: 200000
Operating cash flow: 700000
Depreciation & amortization: 1000000
Net tangible assets: 905900000
Owner earnings: -22600000
Return on net tangible assets (%): -2.494756595650734
Buffett classification: The Gruesome
Stock price: 42.49
P/E ratio: 71.77238086018518
Shares outstanding: 18242921
Book value: 955700000
P/B ratio: 0.8110722122946532
Market cap (USD): 775141713.2900001
Debt to equity: 0.040703149523909174
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -600000
Buyback yield (%): 12.139715665746246
Retained earnings: 1453800000
Receivables turnover: 0.22944422015879423
Capitalized R&D asset: 0
FCF margin (%): -0.3519061583577713
Revenue growth (%): -28.750522356874214
Rule of 40 score: -29.102428515231985
Financial ratios for EIG — annual report dated 2025-12-31
Total revenue: 858700000
Net income: 10800000
Capital expenditures: 2200000
Operating cash flow: 44700000
Depreciation & amortization: 3600000
Net tangible assets: 905900000
Owner earnings: 12200000
Return on net tangible assets (%): 1.3467270118114583
Buffett classification: The Gruesome
Stock price: 42.49
P/E ratio: 71.77238086018518
Shares outstanding: 18242921
Book value: 955700000
P/B ratio: 0.8110722122946532
Market cap (USD): 775141713.2900001
Debt to equity: 0.040703149523909174
Effective tax rate (%): 10
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 37500000
Buyback yield (%): 23.582784523893878
Retained earnings: 1453800000
Receivables turnover: 1.1555645269815638
Capitalized R&D asset: 0
FCF margin (%): 4.367066495865844
Revenue growth (%): -2.498012944248893
Rule of 40 score: 1.8690535516169509
Financial ratios for EKC.NS — annual report dated 2022-03-31
Total revenue: 222150534.0894105
Gross profit: 95823842.8062772
Operating income: 48445747.06580509
Net income: 34972253.72543848
Capital expenditures: 10638045.62837927
Operating cash flow: 21658855.33430041
Depreciation & amortization: 4619583.278385864
Net tangible assets: 118964908.34761968
Owner earnings: 28953791.375445075
Return on net tangible assets (%): 24.33809413011194
Capex to operating income (%): 21.958678052645865
Buffett classification: The Great
Stock price: 2.92509560859818
P/E ratio: 9.385102843127273
Shares outstanding: 112207682
Book value: 119081353.02650666
P/B ratio: 2.75625183563477
Market cap (USD): 328218197.86918104
Debt to equity: 0.1405800194220581
Current ratio: 2.4672611632062527
Quick ratio: 1.2441516302882294
Effective tax rate (%): 28.768523525065326
Interest coverage ratio: 36.92546839819878
COGS to revenue (%): 56.86535564766625
SG&A to revenue (%): 2.660890703400131
Free cash flow (dilution-adjusted): 10870987.735724647
Buyback yield (%): 0
Retained earnings: 67604325.4648556
Inventory turnover: 2.293106857379228
Receivables turnover: 7.437801148232151
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.70842218051288
FCF margin (%): 4.89352311498352
Rule of 40 score: 4.89352311498352
Financial ratios for EKC.NS — annual report dated 2023-03-31
Total revenue: 153531583.43483558
Gross profit: 57720304.50669915
Operating income: 15462801.461632157
Net income: 9274457.97807552
Capital expenditures: 10022034.104750305
Operating cash flow: 12920085.261875762
Depreciation & amortization: 4817161.997563947
Net tangible assets: 121628514.00730817
Owner earnings: 4069585.870889161
Return on net tangible assets (%): 3.3459143228903017
Capex to operating income (%): 64.81383163082042
Buffett classification: The Good
Stock price: 1.0814859926918394
P/E ratio: 13.084434329455119
Shares outstanding: 112207682
Book value: 121740426.30937882
P/B ratio: 0.9968014737112139
Market cap (USD): 121351036.35542025
Debt to equity: 0.11934379661444965
Current ratio: 2.7591895777967164
Quick ratio: 1.0347989673383573
Effective tax rate (%): 19.87645379528197
Interest coverage ratio: 12.125660251205884
COGS to revenue (%): 62.40493114486911
SG&A to revenue (%): 3.0555870026544345
Free cash flow (dilution-adjusted): 2791047.503045067
Buyback yield (%): 0
Retained earnings: 70790194.88428746
Inventory turnover: 1.4193879355455712
Receivables turnover: 6.848978924284346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.07448138060597
FCF margin (%): 1.817897946861005
Revenue growth (%): -30.88849231708683
Rule of 40 score: -29.070594370225823
Financial ratios for EKC.NS — annual report dated 2024-03-31
Total revenue: 144079625.854419
Gross profit: 60327377.3833793
Operating income: 15880801.055282408
Net income: 11899508.334332654
Capital expenditures: 7887036.814965823
Operating cash flow: 27149538.313946515
Depreciation & amortization: 4703201.822760522
Net tangible assets: 131916296.9180957
Owner earnings: 8715673.342127353
Return on net tangible assets (%): 6.6069724103449845
Capex to operating income (%): 49.663973419919955
Buffett classification: The Good
Stock price: 1.5615403071017273
P/E ratio: 14.72471074320899
Shares outstanding: 112207682
Book value: 131937882.24007675
P/B ratio: 1.3280250920704109
Market cap (USD): 175216818.20945296
Debt to equity: 0.059478472682984465
Current ratio: 3.33866504946367
Quick ratio: 1.514497972179055
Effective tax rate (%): 17.40712532791741
Interest coverage ratio: 19.10966810966811
COGS to revenue (%): 58.1291407264374
SG&A to revenue (%): 3.641342344441855
Free cash flow (dilution-adjusted): 19245712.915217653
Buyback yield (%): 0
Retained earnings: 81311907.90262622
Inventory turnover: 1.451181249610406
Receivables turnover: 6.9485859695795495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.521763718146147
FCF margin (%): 13.357692179645106
Revenue growth (%): -6.15636038459041
Rule of 40 score: 7.2013317950546964
Financial ratios for EKC.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 138803153.36837077
Buffett classification: The Gruesome
Stock price: 2.2963449593884375
Shares outstanding: 112207682
Book value: 138874820.83134258
P/B ratio: 1.8553942566614485
Market cap (USD): 257667544.9653607
Debt to equity: 0.14383396693788383
Current ratio: 2.91248253515265
Quick ratio: 1.493801837153304
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EKC.NS — quarterly report dated 2024-12-31
Total revenue: 42780044.29420678
Gross profit: 20241286.863270774
Operating income: 3431635.3887399463
Net income: 2109803.007343513
Capital expenditures: 0
Depreciation & amortization: 1218090.686560205
Owner earnings: 3327893.693903718
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.144072735750087
P/E ratio: 28.507570479392264
Shares outstanding: 112207682
Market cap (USD): 240581431.7179158
Effective tax rate (%): 34.04333455747338
Interest coverage ratio: 6.413943355119826
COGS to revenue (%): 52.68521293697719
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EKC.NS — quarterly report dated 2025-03-31
Total revenue: 49346504.559270516
Gross profit: 20686228.66495207
Operating income: 3202010.7552022445
Net income: 1558335.281739537
Capital expenditures: 0
Depreciation & amortization: 1231003.0395136778
Net tangible assets: 140562310.03039512
Owner earnings: 2789338.321253215
Return on net tangible assets (%): 1.9844141154553094
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.3753063367954252
P/E ratio: 24.75717804442281
Shares outstanding: 112207682
Book value: 141032265.60673368
P/B ratio: 1.0942172376500336
Market cap (USD): 154319936.09172598
Debt to equity: 0.14116496323742736
Current ratio: 2.8675368198253812
Quick ratio: 1.4537143193109328
Effective tax rate (%): 30.993239729589185
Interest coverage ratio: 6.899244332493703
COGS to revenue (%): 58.079647485252664
Buyback yield (%): 0
Retained earnings: 89962590.60088846
Inventory turnover: 0.5097517361833077
Receivables turnover: 1.6902654867256637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1497190217561926
Revenue growth (%): 15.34935359090536
Rule of 40 score: 15.34935359090536
Financial ratios for EKC.NS — annual report dated 2025-03-31
Total revenue: 175264203.88122514
Gross profit: 79587327.56605096
Operating income: 15669862.052840775
Net income: 11448445.171849426
Capital expenditures: 14098667.290156651
Operating cash flow: 6781622.632686462
Depreciation & amortization: 5627776.478840308
Net tangible assets: 140562310.03039512
Owner earnings: 2977554.3605330847
Return on net tangible assets (%): 2.118316325257617
Capex to operating income (%): 89.97314234556849
Buffett classification: The Gruesome
Stock price: 1.3753063367954252
P/E ratio: 13.479554103222956
Shares outstanding: 112207682
Book value: 141032265.60673368
P/B ratio: 1.0942172376500336
Market cap (USD): 154319936.09172598
Debt to equity: 0.14116496323742736
Current ratio: 2.8675368198253812
Quick ratio: 1.4537143193109328
Effective tax rate (%): 21.149035745985636
Interest coverage ratio: 9.943620178041543
COGS to revenue (%): 54.59008411096511
SG&A to revenue (%): 3.871372256054855
Free cash flow (dilution-adjusted): -7397708.674304418
Buyback yield (%): 0
Retained earnings: 89962590.60088846
Inventory turnover: 1.7017091529088868
Receivables turnover: 6.003323589476635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.520202178758673
FCF margin (%): -4.220889668558774
Revenue growth (%): 21.643988760989487
Rule of 40 score: 17.42309909243071
Financial ratios for EKC.NS — quarterly report dated 2025-06-30
Total revenue: 45270301.895623684
Gross profit: 21909665.340510182
Operating income: 5923238.94219518
Net income: 6036742.3355956
Capital expenditures: 0
Depreciation & amortization: 1250877.6035572197
Owner earnings: 7287619.93915282
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6177158904750761
P/E ratio: 18.704006491659936
Shares outstanding: 112207682
Market cap (USD): 181520150.20477417
Effective tax rate (%): 21.167660094757757
Interest coverage ratio: 12.946291560102303
COGS to revenue (%): 51.60256410256411
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.260367578317265
Rule of 40 score: -8.260367578317265
Financial ratios for EKC.NS — quarterly report dated 2025-09-30
Total revenue: 40629086.809470125
Gross profit: 19393461.1048478
Operating income: 3555806.0879368656
Net income: 1541149.943630214
Capital expenditures: 0
Depreciation & amortization: 1279594.1375422773
Net tangible assets: 144505073.28072152
Owner earnings: 2820744.0811724914
Return on net tangible assets (%): 1.9520034951941083
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6405862457722662
P/E ratio: 16.36900937099894
Shares outstanding: 112207682
Book value: 145118376.5501691
P/B ratio: 1.2685256280795527
Market cap (USD): 184086379.7591883
Debt to equity: 0.1531696706028589
Current ratio: 3.440670874158792
Quick ratio: 1.8040377976916908
Effective tax rate (%): 34.70363288718929
Interest coverage ratio: 7.885
COGS to revenue (%): 52.2670514456962
Buyback yield (%): 0
Inventory turnover: 0.4013038754074611
Receivables turnover: 1.4357196924425322
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2153076777197924
Revenue growth (%): -10.252229147608643
Rule of 40 score: -10.252229147608643
Financial ratios for EKC.NS — quarterly report dated 2025-12-31
Total revenue: 40671716.60911218
Gross profit: 20230589.283725075
Operating income: 5084103.820875571
Net income: 3980171.5495154285
Capital expenditures: 0
Depreciation & amortization: 1509412.9441907096
Owner earnings: 5489584.493706138
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.2954216330622703
P/E ratio: 11.082024680266374
Shares outstanding: 112207682
Market cap (USD): 145356258.65857193
Effective tax rate (%): 29.26153236982775
Interest coverage ratio: 17.75875486381323
COGS to revenue (%): 50.25882610720057
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.10492433620762492
Rule of 40 score: 0.10492433620762492
Financial ratios for ELEG.L — annual report dated 2022-03-31
Total revenue: 0
Operating income: -322877.63157894736
Net income: -322877.63157894736
Capital expenditures: 0
Operating cash flow: -317840.7894736842
Net tangible assets: 1305994.7368421052
Owner earnings: -322877.63157894736
Return on net tangible assets (%): -24.722736047134873
Buffett classification: The Gruesome
Stock price: 0.0003947368421052631
Shares outstanding: 2749991691
Book value: 1305994.7368421052
P/B ratio: 0.8311848473033259
Market cap (USD): 1085523.0359210526
Debt to equity: 0
Current ratio: 28.910578707609247
Quick ratio: 28.910578707609247
Free cash flow (dilution-adjusted): -317840.7894736842
Buyback yield (%): 0
Retained earnings: -322877.63157894736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.722736047134873
Rule of 40 score: 0
Financial ratios for ELEG.L — annual report dated 2023-03-31
Total revenue: 0
Gross profit: -92222.22222222222
Operating income: -672123.4567901234
Net income: -663814.8148148147
Capital expenditures: 0
Operating cash flow: -631390.1234567901
Depreciation & amortization: 0
Net tangible assets: 561562.9629629629
Owner earnings: -663814.8148148147
Return on net tangible assets (%): -118.2084394085291
Buffett classification: The Gruesome
Stock price: 0.0002469135802469136
Shares outstanding: 2749991691
Book value: 561562.9629629629
P/B ratio: 1.2091436559338355
Market cap (USD): 679010.2940740741
Debt to equity: 0
Current ratio: 7.860517028143947
Quick ratio: 7.860517028143947
Free cash flow (dilution-adjusted): -631390.1234567901
Buyback yield (%): 0
Retained earnings: -966761.7283950617
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -119.68799602520302
Rule of 40 score: 0
Financial ratios for ELEG.L — annual report dated 2024-03-31
Total revenue: 0
Gross profit: -278803.7974683544
Operating income: -566515.1898734177
Net income: -1724256.9620253164
Capital expenditures: 7324.050632911392
Operating cash flow: -943031.6455696202
Depreciation & amortization: 325.3164556962025
Net tangible assets: -1148477.2151898735
Owner earnings: -1731255.6962025317
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 2749991691
Book value: -1148477.2151898732
Market cap (USD): 696200.4281012659
Debt to equity: -0.21081299728754754
Current ratio: 0.07674864570732715
Quick ratio: 0.07674864570732715
Interest coverage ratio: -9.667494707737504
Free cash flow (dilution-adjusted): -950355.6962025316
Buyback yield (%): 0
Retained earnings: -2715493.670886076
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEG.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -1962666.6666666667
Buffett classification: The Gruesome
Stock price: 0.00013333333333333334
Shares outstanding: 2749991691
Book value: -1962666.6666666667
Market cap (USD): 366665.5588
Debt to equity: -0.052309782608695655
Current ratio: 0.04096228868660598
Quick ratio: 0.04096228868660598
Buyback yield (%): 0
Retained earnings: -8552000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEG.L — annual report dated 2025-03-31
Total revenue: 0
Gross profit: -506914.2857142857
Operating income: -1219963.6363636362
Net income: -6341242.857142857
Capital expenditures: 993.5064935064935
Operating cash flow: -2042425.974025974
Depreciation & amortization: 1616.8831168831168
Net tangible assets: -2636776.6233766233
Owner earnings: -6340619.480519481
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 2749991691
Book value: -2636776.6233766233
Market cap (USD): 0
Debt to equity: -0.02708935250537108
Current ratio: 0.12177941330218196
Quick ratio: 0.12177941330218196
Interest coverage ratio: -40.347564642212866
Free cash flow (dilution-adjusted): -2126510.3896103897
Retained earnings: -9127268.83116883
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ELEG.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -2636776.6233766233
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 2749991691
Book value: -2636776.6233766233
Market cap (USD): 0
Debt to equity: -0.02708935250537108
Current ratio: 0.12177941330218196
Quick ratio: 0.12177941330218196
Retained earnings: -9127268.83116883
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMO.V — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.15625
Shares outstanding: 296623968
Market cap (USD): 342971463
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMO.V — annual report dated 2022-09-30
Total revenue: 0
Operating income: -15311278.832116786
Net income: -15113697.810218977
Capital expenditures: 236098.54014598537
Operating cash flow: -8972227.737226278
Depreciation & amortization: 10708.029197080292
Net tangible assets: 15167623.357664233
Owner earnings: -15339088.321167883
Return on net tangible assets (%): -101.13046691271515
Buffett classification: The Gruesome
Stock price: 0.5693430656934306
Shares outstanding: 296623968
Book value: 15167623.357664233
P/B ratio: 11.134295421038011
Market cap (USD): 168880799.29927006
Debt to equity: 0
Current ratio: 11.942694955767262
Quick ratio: 11.942694955767262
Free cash flow (dilution-adjusted): -15845118.978102189
Buyback yield (%): 0
Retained earnings: -40185818.24817518
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -100.94711920954948
Rule of 40 score: 0
Financial ratios for EMO.V — annual report dated 2023-09-30
Total revenue: 0
Operating income: -16244762.222222222
Net income: -15921345.185185185
Capital expenditures: 61802.22222222222
Operating cash flow: -15609188.148148147
Depreciation & amortization: 24601.481481481478
Net tangible assets: 29308744.444444444
Owner earnings: -15958545.925925925
Return on net tangible assets (%): -54.44977677626485
Buffett classification: The Gruesome
Stock price: 0.2518518518518518
Shares outstanding: 296623968
Book value: 29308744.44444444
P/B ratio: 2.548908083935511
Market cap (USD): 74705295.64444444
Debt to equity: 0
Current ratio: 7.973851139664379
Quick ratio: 7.973851139664379
Free cash flow (dilution-adjusted): -16852848.148148146
Buyback yield (%): 0
Retained earnings: -35651657.777777776
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.426332755449934
Rule of 40 score: 0
Financial ratios for EMO.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: -6598.518518518518
Buffett classification: The Gruesome
Stock price: 0.4962962962962963
Shares outstanding: 296623968
Market cap (USD): 147213376.7111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMO.V — annual report dated 2024-09-30
Total revenue: 0
Operating income: -3063333.333333333
Net income: -2627319.259259259
Capital expenditures: 7054800
Operating cash flow: -1521660.7407407407
Depreciation & amortization: 120137.03703703702
Net tangible assets: 31502613.333333332
Owner earnings: -9561982.222222222
Return on net tangible assets (%): -30.352980944931833
Buffett classification: The Gruesome
Stock price: 0.4962962962962963
Shares outstanding: 296623968
Book value: 31502613.333333336
P/B ratio: 4.673052840201757
Market cap (USD): 147213376.7111111
Debt to equity: 0.13507742379421173
Current ratio: 5.420367106894396
Quick ratio: 5.420367106894396
Interest coverage ratio: -23.05980885255774
Free cash flow (dilution-adjusted): -8607820
Buyback yield (%): 0
Retained earnings: -34942734.074074075
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.566870227628712
Rule of 40 score: 0
Financial ratios for EMO.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -567674.8251748251
Net income: -752776.9230769231
Capital expenditures: 1950986.013986014
Operating cash flow: -1136488.111888112
Depreciation & amortization: 20658.74125874126
Net tangible assets: 29553179.720279723
Owner earnings: -2683104.195804196
Return on net tangible assets (%): -9.07890190226475
Buffett classification: The Gruesome
Stock price: 0.8391608391608392
Shares outstanding: 296623968
Book value: 29553179.720279723
P/B ratio: 8.42262051860665
Market cap (USD): 248915217.9020979
Debt to equity: 0.15530748682113815
Current ratio: 7.404950669198622
Quick ratio: 7.404950669198622
Interest coverage ratio: -1.9505194817676794
Free cash flow (dilution-adjusted): -3087474.125874126
Buyback yield (%): 0
Retained earnings: -33545224.475524478
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6626384980787514
Rule of 40 score: 0
Financial ratios for EMO.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -3213944.0559440563
Net income: -3665513.286713287
Capital expenditures: 1612040.5594405595
Operating cash flow: -1140752.4475524477
Depreciation & amortization: 342.65734265734267
Net tangible assets: 34639472.02797203
Owner earnings: -5277211.188811189
Return on net tangible assets (%): -15.234675587866182
Buffett classification: The Gruesome
Stock price: 0.993006993006993
Shares outstanding: 296623968
Book value: 34639472.02797203
P/B ratio: 8.503295728053478
Market cap (USD): 294549674.5174825
Debt to equity: 0.1415293337797567
Current ratio: 11.585830295616198
Quick ratio: 11.585830295616198
Interest coverage ratio: -10.144913460286206
Free cash flow (dilution-adjusted): -5237116.083916084
Buyback yield (%): 0
Retained earnings: -37210737.762237765
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.127930341949465
Rule of 40 score: 0
Financial ratios for EMO.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1895869.3430656933
Net income: -2112886.8613138683
Capital expenditures: 2588570.0729927006
Operating cash flow: -328963.503649635
Depreciation & amortization: 6967.883211678832
Net tangible assets: 35139280.2919708
Owner earnings: -4694489.05109489
Return on net tangible assets (%): -13.35966192844184
Buffett classification: The Gruesome
Stock price: 1.0291970802919708
Shares outstanding: 296623968
Book value: 35139280.2919708
P/B ratio: 8.687842188958419
Market cap (USD): 305284521.810219
Debt to equity: 0.14768348121409
Current ratio: 6.283027232703574
Quick ratio: 6.283027232703574
Interest coverage ratio: -5.953449086012262
Free cash flow (dilution-adjusted): -3966037.9562043794
Buyback yield (%): 0
Retained earnings: -40953291.97080292
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.701034202149098
Rule of 40 score: 0
Financial ratios for EMO.V — annual report dated 2025-09-30
Total revenue: 0
Operating income: -7936580.575539568
Net income: -8997769.784172662
Capital expenditures: 9076360.431654677
Operating cash flow: -3382851.798561151
Depreciation & amortization: 95329.4964028777
Net tangible assets: 50869453.237410076
Owner earnings: -17978800.71942446
Return on net tangible assets (%): -35.34301938634286
Buffett classification: The Gruesome
Stock price: 1.1438848920863312
Shares outstanding: 296623968
Book value: 50869453.23741007
P/B ratio: 6.670086938861984
Market cap (USD): 339303675.6258993
Debt to equity: 0.11018390423561286
Current ratio: 20.955211100087773
Quick ratio: 20.955211100087773
Interest coverage ratio: -5.941264571972051
Free cash flow (dilution-adjusted): -17479332.374100722
Buyback yield (%): 0
Retained earnings: -42934957.55395684
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.053400835773658
Rule of 40 score: 0
Financial ratios for EMO.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2177547.482014389
Net income: -2369848.9208633094
Capital expenditures: 2859476.258992806
Operating cash flow: -715848.9208633094
Depreciation & amortization: 66856.11510791368
Net tangible assets: 50869453.237410076
Owner earnings: -5162469.0647482015
Return on net tangible assets (%): -10.148465800594948
Buffett classification: The Gruesome
Stock price: 1.1438848920863312
Shares outstanding: 296623968
Book value: 50869453.23741007
P/B ratio: 6.670086938861984
Market cap (USD): 339303675.6258993
Debt to equity: 0.11018390423561286
Current ratio: 20.955211100087773
Quick ratio: 20.955211100087773
Interest coverage ratio: -5.4899805923856855
Free cash flow (dilution-adjusted): -5006212.949640288
Buyback yield (%): 0
Retained earnings: -42934957.55395684
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8558101076920472
Rule of 40 score: 0